Skip to main content
BrainCited

Uridine Monophosphate per Neurotransmitter Imbalance

C

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Dogs with intervertebral disc herniation

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes Effetto: None None

Popolazione: LPS-induced inflammatory astrocyte model

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs: None Outcome: None Effetto: None P = 0.013

Popolazione: Healthy adults

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs: None Outcome: Cognitive function Effetto: None None

Popolazione: Sprague Dawley rats

Key Statistics

4

Studi

300

Partecipanti

Positive

C

Grado

Referenced Papers

Aging and disease 2023 9 citazioni
Clinical pharmacokinetics 2018 128 citazioni
Autonomic neuroscience : … 2015 81 citazioni
European journal of … 2011 16 citazioni
Annual review of … 2009 141 citazioni
The European journal … 2007 55 citazioni
Journal of neuroscience … 1996 16 citazioni
Behavioural brain research 1995 146 citazioni
Journal of steroid … 1984 22 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

Limite massimo: Not established; well-tolerated up to 1,000 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Neutral --
5 mg/kg 4 weeks Positive --
1 g -- Mixed --
None -- Mixed --
None -- Mixed --

Momento migliore per l'assunzione: Morning; synergizes with DHA and choline sources

Safety & Side Effects

Effetti collaterali segnalati

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

Interazioni note

  • No significant drug interactions established

Livello di assunzione massimo tollerabile: Not established; well-tolerated up to 1,000 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Neurotransmitter Imbalance

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.